The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,691,662 in first-year total cost, median $805,652.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-K (56)]4
- Special Emphasis Panel[ZRG1 AARR-P (57)]4
- AIDS Immunology and Pathogenesis Study Section[AIP]1
Most frequent institutions
- UNIVERSITY OF MARYLAND BALTIMORE2
- AARON DIAMOND AIDS RESEARCH CENTER1
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- CALIFORNIA INSTITUTE OF TECHNOLOGY1
- MONTANA STATE UNIVERSITY - BOZEMAN1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir1R01AI136756-01A1 | LI, QINGSHENGLI, YUXINGREEVES, ROGER KEITH | UNIVERSITY OF MARYLAND BALTIMORE, MD | $805,652 | AIP |
| 2018 | Cytotoxic immunoconjugates to deplete persistent HIV reservoirs1R01AI136758-01 | HARRINGTON, ROBERT D.PINCUS, SETH H. | MONTANA STATE UNIVERSITY - BOZEMAN, MT | $649,327 | ZRG1 |
| 2017 | Optimizing eCD4-Ig for eradication and a functional cure1R01AI129868-01A1 | FARZAN, MICHAEL R. | SCRIPPS FLORIDA, FL | $966,508 | ZRG1 |
| 2017 | Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells1R01AI129802-01 | HO, DAVID D | AARON DIAMOND AIDS RESEARCH CENTER, NY | $930,446 | ZRG1 |
| 2017 | Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoir1R01AI129795-01A1 | NUSSENZWEIG, MICHEL CRAVETCH, JEFFREY VICTOR | ROCKEFELLER UNIVERSITY, NY | $847,498 | ZRG1 |
| 2017 | Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs1R01AI129801-01A1 | HESSELL, ANN JONES | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $834,876 | ZRG1 |
| 2017 | Optimization of Broadly Neutralizing Antibodies for HIV Eradication1R01AI129797-01 | ALTER, GALITBAROUCH, DAN H. | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $748,107 | ZRG1 |
| 2017 | Unlocking Env: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity1R01AI129769-01 | FINZI, ANDRESPAZGIER, MARZENA ELZBIETA | UNIVERSITY OF MARYLAND BALTIMORE, MD | $498,498 | ZRG1 |
| 2017 | Targeting the HIV reservoir using optimized anti-HIV antibodies1R01AI129784-01 | BJORKMAN, PAMELA J | CALIFORNIA INSTITUTE OF TECHNOLOGY, CA | $410,750 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.